Biotech directory

The Best Biotech Startups in Europe

Biotech is the science of engineering biology to treat disease and make new materials, and Europe is one of its deepest talent pools. The field here runs from drug discovery and computational biology to synthetic biology and advanced therapies, anchored by world-class universities and research hospitals. This is the science layer beneath digital health, not the software on top of it.

Why biotech now

Machine learning is compressing the discovery cycle, the tools to read and write DNA keep getting cheaper, and a wave of advanced therapies is moving from lab to clinic. Europe pairs that with strong public research and a growing base of specialist investors, which is why the companies below can build platforms that travel worldwide.

7 biotech startups across Europe

A curated, editorial list of European companies.

  • BioNTech

    Mainz, Germany

    BioNTech develops messenger RNA based vaccines and therapies, including treatments for cancer and infectious diseases.

  • bit.bio

    Cambridge, United Kingdom

    Reprograms stem cells into consistent human cells for research and therapy development.

  • Cradle

    Amsterdam, Netherlands

    Cradle builds machine learning software that helps scientists design and engineer improved proteins.

  • CureVac

    Tubingen, Germany

    Works on messenger RNA based vaccines and therapies across infectious disease and oncology.

  • DNA Script

    Paris, France

    Builds benchtop systems that synthesize DNA on demand using an enzymatic process.

  • Isomorphic Labs

    London, United Kingdom

    Uses AI models of molecular structure to design new medicines.

  • Owkin

    Paris, France

    Owkin uses artificial intelligence and federated data to support drug discovery and biomedical research.

Did we miss one?

Tell us about a European biotech startup that should be on this list. We review every suggestion.

For investors

Source startups like these across Europe.

Floancer gives investors a ranked Radar of startups matched to their focus, from pre-seed to Series X. Set a biotech focus and reach out directly.